Australia markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
51.84-0.59 (-1.13%)
As of 01:59PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
24,966,000
21,979,000
9,616,000
16,273,000
11,153,000
Depreciation & amortisation
5,171,000
5,191,000
4,777,000
6,010,000
6,384,000
Deferred income taxes
-6,817,000
-4,293,000
-1,468,000
614,000
-2,205,000
Stock-based compensation
1,096,000
1,182,000
756,000
718,000
949,000
Change in working capital
13,355,000
12,804,000
-275,000
-4,031,000
-926,000
Accounts receivable
-
-3,811,000
-1,249,000
-742,000
-644,000
Inventory
-
-1,125,000
-736,000
-1,050,000
-717,000
Accounts payable
-
1,242,000
353,000
-564,000
431,000
Other working capital
31,783,000
29,869,000
11,612,000
9,994,000
13,631,000
Other non-cash items
-3,623,000
-4,696,000
-2,268,000
-1,745,000
-2,960,000
Net cash provided by operating activities
34,583,000
32,580,000
14,403,000
12,588,000
15,827,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,800,000
-2,711,000
-2,791,000
-2,594,000
-2,196,000
Acquisitions, net
-6,225,000
0
-
-10,861,000
0
Purchases of investments
-49,970,000
-47,613,000
-14,402,000
-7,036,000
-13,474,000
Sales/maturities of investments
39,257,000
28,096,000
12,730,000
16,340,000
19,908,000
Other investing activities
-482,000
-306,000
274,000
206,000
287,000
Net cash used for investing activities
-20,232,000
-22,546,000
-4,271,000
-3,945,000
4,525,000
Cash flows from financing activities
Debt repayment
-3,709,000
-2,100,000
-30,329,000
-12,633,000
-9,620,000
Common stock repurchased
-2,000,000
0
-
-8,865,000
-12,198,000
Dividends paid
-8,806,000
-8,729,000
-8,440,000
-8,043,000
-7,978,000
Other financing activities
126,000
16,000
-870,000
-735,000
-589,000
Net cash used provided by (used for) financing activities
-13,588,000
-9,816,000
-21,639,000
-8,486,000
-20,440,000
Net change in cash
703,000
159,000
475,000
125,000
-205,000
Cash at beginning of period
1,809,000
1,825,000
1,350,000
1,225,000
1,431,000
Cash at end of period
2,573,000
1,983,000
1,825,000
1,350,000
1,225,000
Free cash flow
Operating cash flow
34,583,000
32,580,000
14,403,000
12,588,000
15,827,000
Capital expenditure
-2,800,000
-2,711,000
-2,791,000
-2,594,000
-2,196,000
Free cash flow
31,783,000
29,869,000
11,612,000
9,994,000
13,631,000